Document is current
Any future updates will be listed below
-
Authors
Soilly, AL
Robert-Viard, C
Besse, C
Bruel, AL
Gerard, B
Boland, A
Piton, A
Duffourd, Y
Muller, J
Poë, C
Jouan, T
El Doueiri, S
Faivre, L
Bacq-Daian, D
Isidor, B
Genevieve, D
Odent, S
Philip, N
Doco-Fenzy, M
Lacombe, D
Asensio, ML
Deleuze, JF
Binquet, C
,
Arpin, S
Blanchet, P
Blesson, S
Boute-Benejean, O
Busa, T
Colin, E
Coubes, C
Devillard, F
Edery, P
El Chehadeh, S
Fradin, M
Goldenberg, A
Guerrot, A-M
Herenger, Y
Houcinat, N
Jean-Marcais, N
Jouk, P. S.
Lambert, L
Lavillaureix, A
Legendre, M
Leheup, B
Manouvrier, S
Mercier, S
Moutton, S
Nizon, M
Pasquier, L
Petit, F
Pinson, L
Poirsier, C
Pons, L
Putoux, A
Quelin, C
Renaud, M
Rossi, M
Sorlin, A
Spodenkiewicz, M
Thevenon, J
Toutain, A
Van-Gils, J
Vanlerberghe, C
Verloes, A
Vincent, M
Vincent-Delorme, C
Willems, M
Ziegler, A
Thauvin-Robinet, C
Lejeune, C https://orcid.org/0000-0001-7351-0798
-
Funding
Funding for this research was provided by:
French Ministry of Health (PRME-15-0322)
- License Information
-
More Information
Article History
Received: 1 July 2022
Accepted: 4 April 2023
First Online: 21 April 2023
Declarations
:
: The protocol was approved by the Ethics Committee Est I (2016/07)—identification number: 2016-A00350-51 and the French data privacy commission (CNIL, authorization MMS/HGT/OTB/AR177623). No patients were directly involved in this study.
: Consent form signed by the patients for the whole economic DISSEQ study but not required specifically for the micro-costing study.
: The authors declare that they have no competing interests.
